EUREKARE: eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces the signature of a put option for the potential acquisition of Skyepharma to build a new European bio-CDMO leader

Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and a renowned player in the global biopharma and consumer health industries. The company's unique offer

Related Keywords

Paris ,France General ,France ,Saint Quentin Fallavier ,Rhôalpes ,French ,Christophe Jean ,Benoit Mougeot ,Stefan Berchtold ,Calle Florence Coupry ,Laurent Rigaudeau ,Claris Avocats ,Peter Eckenberg ,Michael Kloss ,Alexandre Mouradian ,Oleron Pharma ,Hubert Olivier ,Xavier Mathiot ,Guillaume Destison ,Jacques Lewiner ,Skyehub Bioproduction ,David Lescuyer ,Purpose Acquisition Company ,Kingarticles Of Association ,Fund Ltd ,King Articles Of Association ,Willkie Farr Gallagher ,Aroma Health ,Euronext Paris ,Isabelle Cachard ,Fonds De Renforcement ,Rollover Shareholders ,Market Shares ,Initial Business Combination ,Professional Segment ,Initial Business ,General Segment ,Risk Factors ,Skyehub Model ,Contribution Prospectus ,Initial Business Contribution ,Purchase Agreement ,Put Option Agreement ,Contribution Share ,Market Warrants ,Put Option ,Contribution Agreement ,Des March ,Founder Shares ,Cornerstone Investors ,Initial Founders ,Secured Deposit Accounts ,Founder Warrants ,Ordinary Shares ,French Code ,Willkie Farr ,Special Purpose Acquisition Company ,Sergio De La Calle ,Florence Coupry ,Rodolphe Besserve ,Gefallene Big Techs ,Eurekare ,Zureking ,First ,European ,Pac ,Healthcare ,Edicated ,Biomanufacturing ,Nnounces ,Signature ,Option ,Potential ,Cquisition ,Skyepharma ,Build ,Dmo ,Leader ,